Search research articles
Contact Us
Filters
Showing results (11-20 of 317) with videos related to
Page
of 32
Sort By:
Expert Review of Hematology
|
May 4, 2021
An evaluation of isatuximab, pomalidomide and dexamethasone for adult patients with relapsed and refractory multiple myeloma
Anna Piggin, H Miles Prince
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 27, 2012
Romidepsin for cutaneous T-cell lymphoma
H Miles Prince, Michael Dickinson
Leukemia & Lymphoma
|
July 16, 2005
The adverse prognostic impact of advanced age in multiple myeloma
Linda Mileshkin, H Miles Prince
Bone Marrow Transplantation
|
February 2, 2021
Allogeneic haematopoietic stem cell transplantation for advanced stage mycosis fungoides and Sézary syndrome: never-late, never-never?
H Miles Prince, Chathuri Abeyakoon
Aesthetic Surgery Journal
|
April 21, 2016
Commentary on: Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma
H Miles Prince, Ricky Johnstone
Best Practice & Research. Clinical Haematology
|
September 15, 2018
Integrating novel systemic therapies for the treatment of mycosis fungoides and Sézary syndrome
H Miles Prince, Christiane Querfeld
Leukemia & Lymphoma
|
April 25, 2007
Denileukin diftitox and vision loss
J B Ruddle, H Miles Prince
Expert Review of Anticancer Therapy
|
March 23, 2011
New drug therapies in peripheral T-cell lymphoma
Rebecca A Howman, H Miles Prince
Seminars in Hematology
|
December 14, 2005
Lenalidomide and thalidomide: an evolving paradigm for the management of multiple myeloma
Kenneth C Anderson, H Miles Prince
Current Hematologic Malignancy Reports
|
June 15, 2013
Breast implant-associated anaplastic large cell lymphoma: a systematic review of the literature and mini-meta analysis
Philip A Thompson, H Miles Prince
Page
of 32
Search research articles
Search
Showing results (11-20 of 317) with videos related to
Sort By:
Page
of 32
Expert Review of Hematology
|
May 4, 2021
An evaluation of isatuximab, pomalidomide and dexamethasone for adult patients with relapsed and refractory multiple myeloma
Anna Piggin, H Miles Prince
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 27, 2012
Romidepsin for cutaneous T-cell lymphoma
H Miles Prince, Michael Dickinson
Leukemia & Lymphoma
|
July 16, 2005
The adverse prognostic impact of advanced age in multiple myeloma
Linda Mileshkin, H Miles Prince
Bone Marrow Transplantation
|
February 2, 2021
Allogeneic haematopoietic stem cell transplantation for advanced stage mycosis fungoides and Sézary syndrome: never-late, never-never?
H Miles Prince, Chathuri Abeyakoon
Aesthetic Surgery Journal
|
April 21, 2016
Commentary on: Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma
H Miles Prince, Ricky Johnstone
Best Practice & Research. Clinical Haematology
|
September 15, 2018
Integrating novel systemic therapies for the treatment of mycosis fungoides and Sézary syndrome
H Miles Prince, Christiane Querfeld
Leukemia & Lymphoma
|
April 25, 2007
Denileukin diftitox and vision loss
J B Ruddle, H Miles Prince
Expert Review of Anticancer Therapy
|
March 23, 2011
New drug therapies in peripheral T-cell lymphoma
Rebecca A Howman, H Miles Prince
Seminars in Hematology
|
December 14, 2005
Lenalidomide and thalidomide: an evolving paradigm for the management of multiple myeloma
Kenneth C Anderson, H Miles Prince
Current Hematologic Malignancy Reports
|
June 15, 2013
Breast implant-associated anaplastic large cell lymphoma: a systematic review of the literature and mini-meta analysis
Philip A Thompson, H Miles Prince
Page
of 32